Certara, Inc. Common Stock

CERTNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
5.37 USD
↘ 0.24 (4.28%)AT CLOSE (11:59 AM EDT)
5.43
↗ 0.06 (1.02%)
POST MARKET (AS OF 07:50 PM EDT)
Post Market
AS OF 07:50 PM EDT
5.43
↗ 0.06 (1.02%)
🔴Market: CLOSED
Open?$5.56
High?$5.77
Low?$5.30
Prev. Close?$5.61
Volume?5.2M
Avg. Volume?3.7M
VWAP?$5.43
Rel. Volume?1.41x
Bid / Ask
Bid?$5.35 × 1.5K
Ask?$5.97 × 400
Spread?$0.62
Midpoint?$5.66
Valuation & Ratios
Market Cap?835.4M
Shares Out?155.6M
Float?112.8M
Float %?73.6%
P/E Ratio?N/A
P/B Ratio?0.82
EPS?-$0.10
Dividend?0.00%
Ex-Dividend?N/A

Certara, Inc. Common Stock (CERT) is currently trading at $5.37. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Themes
Biotech - Drug Development›Clinical-Stage PlatformsAI & Machine Learning›AI-Powered Analytics & Decision Systems
Employees
1.6K
Market Cap
835.4M
Industry
SERVICES-PREPACKAGED SOFTWARE
Website
www.certara.com
Listed
2020-12-11
Address
4 RADNOR CORPORATE CENTER, SUITE 350
RADNOR, PA 19087
Phone: (415) 237-8272
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
39
Momentum?
14
Short Sent.?
45
Piotroski F-Score?2/9Weak
Altman Z-Score?2.11Grey
Confidence?69%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?22.42%Squeeze Risk
Short Interest?25.3M
Days to Cover?6.6
Free Float112.8M
Avg Daily Volume3.8M
Settlement Date2026-05-15
Financial Health
Current Ratio?1.88Adequate
Quick Ratio?1.88Adequate
Cash Ratio?1.04Strong
Debt/Equity?0.29Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.82CHEAP▾
P/S?
Peers
100
S&P
67
1.99CHEAP▾
P/FCF?
Peers
100
S&P
83
12.1CHEAP▾
EV/EBITDA?
Peers
100
S&P
71
11.6CHEAP▾
EV/Sales?
Peers
100
S&P
70
2.33CHEAP▾
Returns & Efficiency
ROE?
S&P
14
-1.5%WEAK▾
ROA?
S&P
3
-1.0%WEAK▾
Cash Flow & Enterprise
FCF?$69.1M
Enterprise Value?$978.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist